13D/13G Filings - SANGAMO THERAPEUTICS INC (SGMO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-10
11:52 am
Sale
2020-12-31 13G Sangamo Therapeutics, Inc.
SGMO
The Vanguard Group 8,453,658
5.980%
-34,846decrease
(-0.41%)
Filing
History
2021-02-04
11:42 am
Sale
2020-12-31 13G Sangamo Therapeutics, Inc.
SGMO
Wellington Management Group LLP 229
0.000%
-7,840,453decrease
(-100.00%)
Filing
History
2021-02-01
08:23 am
Purchase
2020-12-31 13G Sangamo Therapeutics, Inc.
SGMO
BlackRock Inc.
BLK
9,566,415
6.800%
32,144increase
(+0.34%)
Filing
History
Goto Prev, 0, 1